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Abstract
The present investigations were aimed to evaluate the antimicrobial and antioxidant efficacies of
budmunchiamine-A (BUA) of Albizia amara. The activity-guided isolation leaded to isolate the
bioactive compound budmunchiamine-A from alkaloid extract of A. amara. The budmunchiamine-A
showed significant broad-spectrum antimicrobial activity with zone of inhibition (ZOI), minimum
inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC)
values varied from 7.3 to 24.5 mm, 0.95 to 62.5 g/mL, and 1.9 to 250 g/mL, respectively. The
budmunchiamine-A exhibited moderate antioxidant activity with inhibitory concentration 50%
(IC50) value of 400 g/mL in 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay and percent inhibition of
-carotene/linoleic acid was 67.8%. The results suggest the possible use of budmunchiamine-A as a
molecular entity for drug development in pharmaceutical industry.
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Introduction
Infectious diseases are the major cause of death, ac-
counting approximately one-half of all deaths in develop-
ing countries. The increasing reports on multidrug resistant
pathogenic microbes to currently available drugs have fur-
ther complicated the treatment of infectious diseases
(Ahmad and Beg, 2001, Iwu et al., 1999). Free radicals and
reactive oxygen species (ROS) are produced in living cells
as unwanted by-products during metabolic process, which
cause oxidative stress related diseases like cancer and dia-
betes in human beings and oxidative reactions in food and
pharmaceutical products (Ebrahimabadi et al., 2010, Me-
dina et al., 2001). A number of synthetic antioxidants and
free radical scavengers have been used to prevent ROS and
oxidative reactions in food and pharmaceutical products
(Kumaran and Karunakaran, 2007). Recent reports stated
that the application of synthetic antioxidants in food pro-
cessing has led to the appearance of remarkable side effects
(Ebrahimabadi et al., 2010). The increasing side-effects of
synthetic antioxidants, and emergence of multidrug resis-
tant pathogenic microbes are collectively necessitated to
look for alternative strategies (Ahmad and Beg, 2001, Iwu
et al., 1999).
In recent decades, plants have provided a source of in-
spiration for novel drug compounds, as plant derived medi-
cines have made large contributions to human health and
well-being (Parekh and Chanda, 2007). Their role is crucial
in the development of new drugs, they may become the
base for the development of a medicine, a natural blueprint
for the development of new therapeutic molecules (Iwu et
al., 1999, Kumaran and Karunakaran, 2007). The bioactive
compounds of plant origin have been screened for their po-
tential uses as alternative agents for the treatment of infec-
tious diseases, preservation of food from microbial deterio-
ration and the effect of oxidants (Dung et al., 2008, Medina
et al., 2001, Reza et al., 2010). Alkaloids are a structurally
diverse group of over 12,000 cyclic nitrogen-containing
compounds that are found in over 20% of plant species,
which are important bioactive substances and have been re-
ported for their various bioactivities (Ahmad et al., 2006,
Deng et al., 2011, Medina et al., 2001, Roy and Chatterjee,
2010).
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The Albizia amara (Leguminosae) is a small to mod-
erate sized deciduous tree, is rich in alkaloids and grows in
tropical regions of southern India. The leaves are used as
folk remedy for curing various diseases viz., stomach can-
cer, common cold, diarrhoea, intestinal ailments, dandruff,
wounds, skin diseases, gonorrhoea and animal fodder
(Ayyanar and Ignacimuthu, 2005, Kareru et al., 2008).
Some biological activities of aqueous and solvent extracts
of A. amara are reported (Kareru et al., 2008, Karmegam et
al., 2012, Khan et al., 2010, Kumar et al., 2010, Muchuweti
et al., 2006, Praveen et al., 2011). Previous reports stated
that the budmunchiamines are the main alkaloid constitu-
ents in this plant (Pezzuto et al., 1991, Pezzuto et al., 1992,
Rajkumar and Sinha, 2010). The budmunchiamines mix-
tures have been reported for some biological activities (Mar
et al., 1991). Although, there are no reports on the anti-
microbial activity against both Gram-positive and Gram-
negative bacteria, and yeasts, and antioxidant activities of
budmunchiamine-A (BUA). Hence, the present study has
made an attempt to analyse the antimicrobial and antioxi-
dant activities of BUA.
Material and Methods
Chemicals and culture media
Mueller-Hinton agar/broth (MHA/MHB), malt ex-
tract-glucose-yeast extract-peptone-agar/broth
(MGYPA/MGYPB), dimethyl sulfoxide (DMSO), -caro-
tene, linoleic acid, neomycin (NM) and fluconazole (FZ)
were purchased from Hi-Media, Mumbai (India). All sol-
vents, reagents, ascorbic acid and iodo-nitro-tetrazolium
(INT) were purchased from SRL, Mumbai. Microtiter-pla-
tes (96-well) were purchased from Axiva, New Delhi (In-
dia). 2,2-diphenyl-1-picrylhydrazyl (DPPH) were obtained
from Sigma, Germany. Silica gel 60 F254-coated prepara-
tive thin-layer chromatography (TLC) plates were obtained
from Merck, Germany.
Plant sample collection
Fresh leaves of Albizia amara (Roxb.) B.Boivin were
collected from the southern part of Karnataka (India) dur-
ing 2010-12. The plant samples were authenticated by Dr.
Sankara Rao, Professor, JCB National Herbarium and au-
thenticated voucher specimens were deposited in JCB Na-
tional Herbarium, Indian Institute of Science, Bangalore
(India) (Voucher number: BUB/MB-BT/DCM/JU10/23).
Isolation and identification of bioactive compounds
from alkaloid extracts
The leaves were shade-dried, powdered and used for
alkaloid extraction following the procedure of Harborne
(1998). The isolation of bioactive compound was done
from the alkaloid extracts of A. amara as reported in our
previous paper (Thippeswamy et al., 2013). Briefly, the ac-
tivity guided isolation of bioactive molecule from alkaloid
extracts of A. amara was done initially by silica gel column
chromatography and further purified by preparative TLC,
and subjected to spectral analysis for structural elucidation.
In IR spectrum, the bioactive compound showed character-
istic absorption peaks at 1649.61, 3359.77, and 2945.54
confirmed the presence of strong C=O stretch, N-H stretch
and alkane C-H stretch, respectively. In the positive mode
[M+H]+ electro-spray ionization mass spectroscopy, active
compound showed molecular ion peak (m/z) at 453.88 cor-
responding to the molecular formula C27H56N4O (MW.
452.76), respectively. Further, based on NMR spectro-
scopic analysis and cited literature data (Pezzuto et al.,
1991, Pezzuto et al., 1992), the isolated compound was
identified as budmunchiamine-A (Figure 1).
Antimicrobial activities
Microbial strains
The pathogenic Escherichia coli (NCIM 2065),
Klebsiella pneumoniae (NCIM 2957), Proteus vulgaris
(NCIM 2027), Pseudomonas aeruginosa (NCIM 5031),
Salmonella typhi (NCIM 2051), Staphylococcus aureus
(NCIM 2079), Streptococcus faecalis (NCIM 5025),
Candida albicans (NCIM 3471) and Cryptococcus
neoformans (NCIM 3541) were obtained from the National
Chemical Laboratory, Pune (India). All the tested bacteria
and fungi were maintained on MHA and MGYPA, respec-
tively. Twenty four hours old bacterial and 48 h old fungal
cultures were used as test organisms.
Disc diffusion method
The disc diffusion method was employed for the de-
termination of zones of inhibition (ZOI) according to the
method described by Ebrahimabadi et al. (2010) with slight
modifications. Briefly, sterile filter paper discs (6 mm in di-
ameter) were individually impregnated with 20 L of two-
fold diluted BUA dissolved in DMSO (0.95 to
1000 g/disc), placed onto the pre-inoculated
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Figure 1 - Structure of budmunchiamine-A.
MHA/MGYP plates (inoculum size: 100 L of a microbial
suspension containing 108 cfu/mL of bacteria or 106 cfu/mL
of fungi) and incubated at 37 °C for bacteria (24 h) and
30 °C for fungi (48 h). DMSO served as a negative control,
and twofold diluted neomycin (for bacteria) and fluco-
nazole (for fungi) served as positive controls. The ZOI di-
ameters were measured in millimetres (mm).
Determination of the MICs and MBCs/MFCs
The broth microdilution method was used to deter-
mine the minimum inhibitory concentrations (MICs) and
minimum bactericidal concentrations (MBCs)/minimum
fungicidal concentrations (MFCs) following the standard
procedures with some modifications (Dung et al., 2008,
Hajji et al., 2010). Briefly, 200 L of two-fold serially di-
luted BUA in MHB or MGYPB (0.95 to 1000 g/mL) was
added to the wells of a sterile 96-well microtiter plate and
inoculated with 15 L of a microbial suspension containing
108 cfu/mL of bacteria or 106 cfu/mL of fungi, respectively,
and incubated at 37 °C for bacteria (24 h) and 30 °C for
fungi (48 h). DMSO served as a negative control, and
neomycin and fluconazole were used as positive controls.
After incubation, the MIC values of the compounds were
detected by the addition of 50 L of INT (2 mg/mL) accord-
ing to the procedure of Hajji et al. (2010). MIC was defined
as the lowest concentration at which no visible microbial
growth was observed. The MBC/MFC values were deter-
mined following the procedure of Dung et al. (2008). Fifty
microlitre of cultured broth (without INT) was radially
streaked onto the MHA/MGYPA media and further incu-
bated for respective time and temperature as mentioned
above. The complete absence of growth on the agar surface
at the lowest concentration was defined as the MBC/MFC.
Antioxidant activity
The antioxidant activity was determined by DPPH
radical scavenging and -carotene/linoleic acid assays
(Ebrahimabadi et al., 2010). In DPPH assay, two-fold dilu-
tions of BUA was made using methanol (ranging from 31 to
1000 g/mL). One millilitre of each dilution was mixed
with 3 mL of freshly prepared methanol solution of DPPH
(40 g/mL) and incubated for 30 min in the dark at room
temperature. The same concentration of ascorbic acid was
used as positive control and methanol solution of DPPH
served as negative control. The absorbance of the solutions
was recorded using UV-Vis spectrophotometer (ELICO,
SL-210 double beam spectrophotometer) at 517 nm. Per-
cent inhibition of DPPH radical was calculated by follow-
ing formula.
I % = {(Acontrol - Asample)/Acontrol} x 100
where Acontrol is the absorbance of the control reaction and
Asample is the absorbance of the test samples.
In -carotene/linoleic acid assay, 500 L of BUA
(2000 g in 1000 L of methanol) was added to 2500 L of
-carotene-linoleic acid emulsion mixture separately,
mixed thoroughly and incubated at 50 °C for 2 h in water
bath. Methanol was used as negative control and ascorbic
acid was used as positive control. The absorbance was mea-
sured at 470 nm using UV-Vis spectrophotometer. The an-
tioxidant activity (Inhibitions percentage) was calculated
using following formula
I% = (A
-carotene after 2 h/Ainitial -carotene) x 100
where, A
-carotene after 2 h is the absorbance of -carotene after
2 h and Ainitial -carotene is the absorbance of -carotene at the
beginning.
Statistical analysis
Data given of all tests were expressed as means of
four replicates  standard error. Analysis of variance was
conducted, and the differences between values were tested
for significance by ANOVA by applying Tukey’s multiple
comparison tests with the SPSS 20 (IBM, USA) program-
me. Differences at p  0.05 were considered statistically
significant.
Results and Discussion
As a result of the emergence of multidrug resistant
bacteria and fungi, and the increasing occurrence of oppor-
tunistic systemic mycosis led renewed interest to search
new bioactive molecules. In this way, we demonstrated the
bioactive properties of active constituent BUA of A. amara,
which is responsible for antimicrobial and antioxidant ac-
tivities. The antimicrobial efficacy of bioactive compound
was determined by employing disc diffusion and broth
microdilution techniques. The isolated BUA showed a con-
centration-dependent bactericidal activity against both
Gram-positive and Gram-negative bacteria, and antifungal
activity against C. albicans and C. neoformans (Table 1).
The negative control DMSO did not inhibit any tested mi-
croorganisms. The BUA displayed significant activity
against Gram-positive and Gram-negative bacteria with
ZOI, MIC and MBC ranged 7.3-24.5 mm, 0.95-62.5 g/mL
and 1.9-250 g/mL, respectively. Similarly, the antifungal
activity with ZOI, MIC and MFC ranged 13.5-13.8 mm, 7.8
g/mL and 15.6 g/mL, respectively. Among the bacteria
tested, the Gram-positive S. faecalis was the most suscepti-
ble species followed by S. aureus, whereas the Gram-
negative P. vulgaris was the most resistant. The antibacte-
rial and antifungal activities of the synthetic antibacterial
(neomycin) and antifungal (fluconazole) agents were also
determined and compared with the MIC and MBC/MFC
values of BUA. The increasing order of the inhibitory activ-
ity against bacteria was BUA < neomycin and fungi was
fluconazole < BUA.
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The DPPH radicals scavenging and -carotene blea-
ching assays were used to determine the antioxidant po-
tency of BUA. Antioxidants on interaction with DPPH,
either transfer electrons or hydrogen atoms to DPPH, thus
neutralizing the free radical character (Dung et al., 2008).
The reduction in intensity of DPPH solution in the presence
of antioxidants at 517 nm is usually taken as a measure of
their antioxidant activity. Similarly, -carotene/linoleic
acid method is based on the loss of orange colour of -caro-
tene due to its reaction with radicals formed in linoleic acid
oxidation in an emulsion. The rate of -carotene bleaching
can be delayed down in the presence of antioxidant (Oke et
al., 2009). In the DPPH assay, the IC50 value was found to
be 400 g/mL, whereas the -carotene/linoleic acid assay
showed 67.8% inhibition of -carotene/linoleic bleaching
at 1000 g/mL, and the activities were compared with the
synthetic antioxidant ascorbic acid (Table 2). The increas-
ing order of antioxidant activity was BUA < ascorbic acid.
The results of the present investigation confirmed the
strong antimicrobial activity of BUA against Gram-posi-
tive bacteria than Gram-negative bacteria and yeast. These
results are of great importance, particularly for S. aureus,
which is well known for being resistant to a number of anti-
biotics (Dung et al., 2008). Mar et al. (1991) have reported
the bactericidal activity of mixture of budmunchiamines
isolated from A. amara, against only one Gram-negative S.
typhimurium. Although, this is the first report on
antimicrobial activity of BUA against a wide range of hu-
man pathogenic bacteria and fungi. To the best of our
knowledge, we have been reporting here the antioxidant ac-
tivity of BUA for the first time. The above results suggest
the possible use of BUA as a potent chemical entity for de-
veloping pharmacologically important drugs. The in vivo
toxicological studies on BUA and its mode of action are be-
ing investigated for further exploitation.
Acknowledgments
This work was financially supported by the Science
and Engineering Research Board, Department of Science
and Technology, New Delhi, India. The authors wish to
thank the Indian Institute of Science, Bangalore, for provid-
ing NMR, FT-IR and mass spectrometric analysis and spec-
tral interpretation.
Conflict of interest statement
We declare that we have no conflict of interest.
References
Ahmad I, Aqil F, Owais M (2006) Modern Phytomedicine - Turn-
ing medicinal plants into drugs. Verlag GmbH and Co.
KGaA, Weinheim.
Ahmad I, Beg AZ (2001) Antimicrobial and phytochemical stud-
ies on 45 Indian medicinal plants against multi-drug resis-
tant human pathogens. J Ethnopharmacol 74:113-123.
Ayyanar M, Ignacimuthu S (2005) Medicinal plants used by the
tribals of Tirunelveli hills, Tamil Nadu to treat poisonous
bites and skin diseases. Indian J Tradit Know 4:229-236.
Deng Y, Yu Y, Luo H, Zhang M, Qin X, Li L (2011) Antimi-
crobial activity of extract and two alkaloids from traditional
Chinese medicinal plant Stephania dielsiana. Food Chem
124:1556-1560.
Dung NT, Kim JM, Kang SC (2008) Chemical composition,
antimicrobial and antioxidant activities of the essential oil
142 Thippeswamy et al.
Table 1 - Antimicrobial activity of BUA against bacteria and yeast.
Organisms BUA Neomycin/Fluconazole
ZOIa MICb MBCc ZOIa MICb MBCc
E. coli 11.3  0.3 3.9 15.6 16.8  0.2 3.9 7.8
K. pneumoniae 10.1  0.2 7.8 15.6 17.1  0.2 1.9 3.9
P. vulgaris 7.3  0.2 62.5 250 20.3  0.3 1.9 3.9
P. aeruginosa 9.1  0.2 15.6 31.2 16.6  0.2 1.9 7.8
S. typhi 11.5  0.3 7.8 31.2 19.5  0.3 1.9 3.9
S. aureus 14.3  0.2 15.6 31.2 19.5  0.4 0.95 3.9
S. faecalis 24.5  0.3 0.95 1.9 27.5  0.3 0.95 1.9
C. albicans 13.8  0.2 7.8 15.6 33.3  0.4* 31.2 > 1000
C. neoformans 13.5  0.3 7.8 15.6 35.7  0.3* 15.6 500
Notes: aZOIs at 0.25 mg/disc (mm); bMICs (g/mL) & cMBCs/MFCs (g/mL); Neomycin was used as positive control for bacteria and fluconazole for
fungi; *fungistatic zone.
Table 2 - Determination of antioxidant activity of BUA.
Samples DPPH IC50
(g/mL)
-carotene/linoleic acid inhibition (%)
at 1000 g/mL
BUA 400  3.9 67.8  0.8
Ascorbic acid 38  1.2 92.8  0.8
Methanol was used as negative control.
and the ethanol extract of Cleistocalyx operculatus (Roxb.)
Merr and Perry buds. Food Chem Toxicol 46:3632-3639.
Ebrahimabadi AH, Ebrahimabadi EH, Bidgoli ZD, Kashi FJ,
Mazoochi A, Batooli H (2010) Composition and antioxidant
and antimicrobial activity of the essential oil and extracts of
Stachys inflata Benth from Iran. Food Chem 119:452-458.
Hajji M, Masmoudi O, Souissi N, Triki Y, Kammoun S, Nasri M
(2010) Chemical composition, angiotensin I-converting en-
zyme (ACE) inhibitory, antioxidant and antimicrobial activ-
ities of the essential oil from Periploca laevigata root barks.
Food Chem 121:724-731.
Harborne JB (1998) Phytochemical Methods: A Guide to Modern
Techniques of Plant Analysis: 3rd edition. Chapan and Hall
Publication, London.
Iwu MM., Duncan, AR. Okunji CO (1999) New antimicrobials of
plant origin. In: J. Janick (ed) Perspectives on New Crops
and New Uses. ASHS Press, Alexandria.
Kareru PG, Gachanja AN, Keriko JM, Kenji GM (2008) Anti-
microbial activity of some medicinal plants used by herbal-
ists in eastern province, Kenya. Afr J Tradit Complement
Altern Med 5:51-55.
Karmegam N, Jayakumar M, Karuppuswamy S (2012) Synergis-
tic antibacterial activity of four medicinal plants collected
from Dharapuram Taluk of Tiruppur District, south India. J
Plant Sci 7:32-38.
Khan A, Shah RD, Pallewar S (2010) Evaluation of anti-inflam-
matory and analgesic activity of ethanolic extracts of
Inularacemosa and Albizia amara. Int J Pharmacog
Phytochem Res 3:22-27.
Kumar PS, Sucheta S, Umamaheswari A, Deepa VS (2010). In vi-
tro and in vivo evaluation of anti-dandruff activity of formu-
lated polyherbal hair oil. J Pharm Res 3:2956-2958.
Kumaran A, Karunakaran RJ (2007). Activity-guided isolation
and identification of free radical-scavenging components
from an aqueous extract of Coleus aromaticus. Food Chem
100:356-361.
Mar W, Tan GT, Cordell GA, Pezzuto JM (1991) Biological ac-
tivity of novel macrocyclic alkaloids (Budmunchiamines)
from Albizia amara detected on the basis of interaction with
DNA. J Nat Prod 54:1531-1542.
Medina AS, Sosa KG, Pat FM, Rodriguez LMP (2001) Evaluation
of biological activity of crude extracts from plants used in
Yucatecan Traditional Medicine Part I. Antioxidant, anti-
microbial and -glucosidase inhibition activities. Phytome-
dicine 8:144-151.
Muchuweti M, Nyamukonda L, Chagonda S, Ndhlala AR, Mu-
pure C, Benhura M (2006) Total phenolic content and anti-
oxidant activity in selected medicinal plants of Zimbabwe.
Int J Food Sci Technol 41:33-38.
Oke F, Aslim B, Ozturk S, Altundag S (2009) Essential oil com-
position, antimicrobial and antioxidant activities of Satureja
cuneifolia Ten. Food Chem 112:874-879.
Parekh J, Chanda S (2007) Antibacterial and phytochemical stud-
ies on twelve species of Indian medicinal plants. Afri J
Biomed Res 10:175-181.
Pezzuto JM, Mar W, Lin LZ, Cordell GA, Neszmelyi A, Wagner
H (1992) Budmunchiamines D-I from Albizia amara.
Phytochemistry 31:1795-1800.
Pezzuto JM, Mar W, Lin LZ, Cordell GA (1991) DNA-based iso-
lation and the structure elucidation of Budmunchiamines,
novel macrocyclic alkaloids from Albizia amara. Hetero-
cycles 32:1961-1967.
Praveen P, Thippeswamy S, Mohana DC, Manjunath K (2011)
Antimicrobial efficacy and phytochemical analysis of
Albizia amara (Roxb.) Boiv. an indigenous medicinal plant
against some human and plant pathogenic bacteria and
fungi. J Pharm Res 4:832-835.
Rajkumar T, Sinha BN (2010) Chromatographic finger print anal-
ysis of Budmunchiamines in Albizia amara by HPTLC tech-
nique. Int J Res Pharm Sci 1:313-316.
Reza SMA, Rahman A, Ahmed Y, Kang SC (2010) Inhibition of
plant pathogens in vitro and in vivo with essential oil and or-
ganic extracts of Cestrum nocturnum L. Pestic Biochem
Physiol 96:86-92.
Roy S, Chatterjee P (2010) A non-toxic antifungal compound
from the leaves of Catharanthus roseus characterized as
5-hydroxy flavone by UV spectroscopic analysis and evalu-
ation of its antifungal property by agar-cup method. Ind
Crops Prod 32:375-380.
Thippeswamy S, Mohana DC, Abhishek RU, Manjunath K (2013)
Efficacy of bioactive compounds isolated from Albizia
amara and Albizia saman as source of antifungal and
antiaflatoxigenic agents. J Verbr Lebensm 8:297-395.
Associate Editor: Roxane Maria Fontes Piazza
All the content of the journal, except where otherwise noted, is licensed under a
Creative Commons License CC BY-NC.
Bioactivities of budmunchiamine-A 143
